Cargando…

Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders

OBJECTIVE: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. METHODS: In 2014, the Alternating Hemiplegia of Childhood Foundati...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosewich, Hendrik, Sweney, Matthew T., DeBrosse, Suzanne, Ess, Kevin, Ozelius, Laurie, Andermann, Eva, Andermann, Frederick, Andrasco, Gene, Belgrade, Alice, Brashear, Allison, Ciccodicola, Sharon, Egan, Lynn, George, Alfred L., Lewelt, Aga, Magelby, Joshua, Merida, Mario, Newcomb, Tara, Platt, Vicky, Poncelin, Dominic, Reyna, Sandra, Sasaki, Masayuki, Sotero de Menezes, Marcio, Sweadner, Kathleen, Viollet, Louis, Zupanc, Mary, Silver, Kenneth, Swoboda, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335249/
https://www.ncbi.nlm.nih.gov/pubmed/28293679
http://dx.doi.org/10.1212/NXG.0000000000000139
_version_ 1782512007430275072
author Rosewich, Hendrik
Sweney, Matthew T.
DeBrosse, Suzanne
Ess, Kevin
Ozelius, Laurie
Andermann, Eva
Andermann, Frederick
Andrasco, Gene
Belgrade, Alice
Brashear, Allison
Ciccodicola, Sharon
Egan, Lynn
George, Alfred L.
Lewelt, Aga
Magelby, Joshua
Merida, Mario
Newcomb, Tara
Platt, Vicky
Poncelin, Dominic
Reyna, Sandra
Sasaki, Masayuki
Sotero de Menezes, Marcio
Sweadner, Kathleen
Viollet, Louis
Zupanc, Mary
Silver, Kenneth
Swoboda, Kathryn
author_facet Rosewich, Hendrik
Sweney, Matthew T.
DeBrosse, Suzanne
Ess, Kevin
Ozelius, Laurie
Andermann, Eva
Andermann, Frederick
Andrasco, Gene
Belgrade, Alice
Brashear, Allison
Ciccodicola, Sharon
Egan, Lynn
George, Alfred L.
Lewelt, Aga
Magelby, Joshua
Merida, Mario
Newcomb, Tara
Platt, Vicky
Poncelin, Dominic
Reyna, Sandra
Sasaki, Masayuki
Sotero de Menezes, Marcio
Sweadner, Kathleen
Viollet, Louis
Zupanc, Mary
Silver, Kenneth
Swoboda, Kathryn
author_sort Rosewich, Hendrik
collection PubMed
description OBJECTIVE: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. METHODS: In 2014, the Alternating Hemiplegia of Childhood Foundation hosted a multidisciplinary workshop intended to address fundamental challenges surrounding the diagnosis and management of individuals with ATP1A3-related disorders. RESULTS: Workshop attendees were charged with the following: (1) to achieve consensus on expanded diagnostic criteria to facilitate the identification of additional patients, intended to supplement existing syndrome-specific diagnostic paradigms; (2) to standardize definitions for the broad range of paroxysmal manifestations associated with AHC to disseminate to families; (3) to create clinical recommendations for common recurrent issues facing families and medical care providers; (4) to review data related to the death of individuals in the Alternating Hemiplegia of Childhood Foundation database to guide future efforts in identifying at-risk subjects and potential preventative measures; and (5) to identify critical gaps where we most need to focus national and international research efforts. CONCLUSIONS: This report summarizes recommendations of the workshop committee, highlighting the key phenotypic features to facilitate the diagnosis of possible ATP1A3 mutations, providing recommendations for genetic testing, and outlining initial acute management for common recurrent clinical conditions, including epilepsy.
format Online
Article
Text
id pubmed-5335249
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-53352492017-03-14 Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders Rosewich, Hendrik Sweney, Matthew T. DeBrosse, Suzanne Ess, Kevin Ozelius, Laurie Andermann, Eva Andermann, Frederick Andrasco, Gene Belgrade, Alice Brashear, Allison Ciccodicola, Sharon Egan, Lynn George, Alfred L. Lewelt, Aga Magelby, Joshua Merida, Mario Newcomb, Tara Platt, Vicky Poncelin, Dominic Reyna, Sandra Sasaki, Masayuki Sotero de Menezes, Marcio Sweadner, Kathleen Viollet, Louis Zupanc, Mary Silver, Kenneth Swoboda, Kathryn Neurol Genet Article OBJECTIVE: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. METHODS: In 2014, the Alternating Hemiplegia of Childhood Foundation hosted a multidisciplinary workshop intended to address fundamental challenges surrounding the diagnosis and management of individuals with ATP1A3-related disorders. RESULTS: Workshop attendees were charged with the following: (1) to achieve consensus on expanded diagnostic criteria to facilitate the identification of additional patients, intended to supplement existing syndrome-specific diagnostic paradigms; (2) to standardize definitions for the broad range of paroxysmal manifestations associated with AHC to disseminate to families; (3) to create clinical recommendations for common recurrent issues facing families and medical care providers; (4) to review data related to the death of individuals in the Alternating Hemiplegia of Childhood Foundation database to guide future efforts in identifying at-risk subjects and potential preventative measures; and (5) to identify critical gaps where we most need to focus national and international research efforts. CONCLUSIONS: This report summarizes recommendations of the workshop committee, highlighting the key phenotypic features to facilitate the diagnosis of possible ATP1A3 mutations, providing recommendations for genetic testing, and outlining initial acute management for common recurrent clinical conditions, including epilepsy. Wolters Kluwer 2017-03-02 /pmc/articles/PMC5335249/ /pubmed/28293679 http://dx.doi.org/10.1212/NXG.0000000000000139 Text en Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Rosewich, Hendrik
Sweney, Matthew T.
DeBrosse, Suzanne
Ess, Kevin
Ozelius, Laurie
Andermann, Eva
Andermann, Frederick
Andrasco, Gene
Belgrade, Alice
Brashear, Allison
Ciccodicola, Sharon
Egan, Lynn
George, Alfred L.
Lewelt, Aga
Magelby, Joshua
Merida, Mario
Newcomb, Tara
Platt, Vicky
Poncelin, Dominic
Reyna, Sandra
Sasaki, Masayuki
Sotero de Menezes, Marcio
Sweadner, Kathleen
Viollet, Louis
Zupanc, Mary
Silver, Kenneth
Swoboda, Kathryn
Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders
title Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders
title_full Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders
title_fullStr Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders
title_full_unstemmed Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders
title_short Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders
title_sort research conference summary from the 2014 international task force on atp1a3-related disorders
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335249/
https://www.ncbi.nlm.nih.gov/pubmed/28293679
http://dx.doi.org/10.1212/NXG.0000000000000139
work_keys_str_mv AT rosewichhendrik researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT sweneymatthewt researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT debrossesuzanne researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT esskevin researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT ozeliuslaurie researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT andermanneva researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT andermannfrederick researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT andrascogene researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT belgradealice researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT brashearallison researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT ciccodicolasharon researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT eganlynn researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT georgealfredl researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT leweltaga researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT magelbyjoshua researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT meridamario researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT newcombtara researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT plattvicky researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT poncelindominic researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT reynasandra researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT sasakimasayuki researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT soterodemenezesmarcio researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT sweadnerkathleen researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT violletlouis researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT zupancmary researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT silverkenneth researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders
AT swobodakathryn researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders